Bonvini Ezio 4

What Happened
Ezio Bonvini, Senior Vice President, Research & Chief Scientific Officer at MacroGenics (MGNX), had restricted stock units (RSUs) vest and convert into 18,167 shares on Feb 7–8, 2026 (7,001 on Feb 7 and 11,166 on Feb 8). To satisfy tax withholding, 2,703 shares were withheld on Feb 7 (proceeds $4,892 at $1.81/share) and 4,311 shares were withheld on Feb 8 (proceeds $7,803 at $1.81/share), totaling 7,014 shares withheld and approximately $12,695 in tax-withholding proceeds. This was an RSU vesting/conversion event, not an open-market sale or purchase.

Key Details

• Transaction dates: Feb 7, 2026 (7,001 RSUs converted; 2,703 shares withheld) and Feb 8, 2026 (11,166 RSUs converted; 4,311 shares withheld).
• Withholding price recorded: $1.81 per share for the tax-withholding dispositions; total proceeds from withheld shares ≈ $12,695.
• Net new shares delivered to insider: 18,167 converted − 7,014 withheld = 11,153 net shares received.
• Shares owned after transaction: Not specified in the provided filing data.
• Footnotes: F1 notes RSUs convert one-for-one into stock. F2/F3 show these RSUs came from grants on Feb 7, 2025 (21,000 RSUs) and Feb 8, 2024 (33,500 RSUs) with standard multi-year vesting schedules. The withheld-share entries (code F) reflect tax withholding, a routine administrative step.
• Filing: Form 4 filed Feb 10, 2026 reporting Feb 7–8, 2026 transactions (no indication in the provided data that the filing was late).

Context
This was an RSU vest/convert event with shares withheld for taxes (a common administrative transaction). It is not a market sell or a new cash purchase; withheld shares are used to satisfy tax obligations, not an expression of buying or selling intent. For retail investors, purchases by insiders can be more informative about sentiment; RSU vesting and tax withholding are routine compensation actions and do not necessarily indicate a change in the insider’s view of the company.